Stockscreener 앱 받기
6.71
31.05%
1.59
전일 마감가:
$5.12
열려 있는:
$5.56
하루 거래량:
1.15M
Relative Volume:
3.76
시가총액:
$63.68M
수익:
$5.12M
순이익/손실:
$-67.00M
주가수익비율:
-4.5646
EPS:
-1.47
순현금흐름:
$-38.94M
1주 성능:
+49.78%
1개월 성능:
+74.29%
6개월 성능:
+9.69%
1년 성능:
-39.55%
1일 변동 폭
$5.50
$6.79
1주일 범위
$3.90
$6.79
52주 변동 폭
$3.28
$13.60
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
명칭
Verrica Pharmaceuticals Inc
전화
484-453-3300
주소
10 NORTH HIGH STREET, WEST CHESTER, PA
VRCA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
6.71 | 48.59M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-06 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | 업그레이드 | Needham | Hold → Buy |
| 2023-03-22 | 개시 | Jefferies | Buy |
| 2023-02-13 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | 개시 | RBC Capital Mkts | Outperform |
| 2020-12-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-06-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-24 | 개시 | Northland Capital | Outperform |
| 2020-03-24 | 개시 | Needham | Buy |
| 2019-02-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Verrica Pharmaceuticals Inc 주식(VRCA)의 최신 뉴스
Insider Stock Purchases: November 26, 2025 - Quiver Quantitative
Verrica Pharmaceuticals Insider Bought Shares Worth $17,505,157, According to a Recent SEC Filing - MarketScreener
Verrica Pharmaceuticals announces $50M PIPE financing - MSN
Insider Buying: John Kirby Acquires Shares of Verrica Pharmaceuticals Inc (VRCA) - GuruFocus
Caligan Partners LP Significantly Increases Stake in Verrica Pharmaceuticals Inc - GuruFocus
Verrica arranges $50M financing to pay off debt, pursue 'billion-dollar market opportunities' - The Business Journals
Watkins Advises on Verrica Pharmaceuticals’ US$50 Million Private Placement Financing - Latham & Watkins LLP
Is Verrica Pharmaceuticals Inc 1NE a good long term investmentPrice Channel Trading & Free Phenomenal Capital Appreciation - earlytimes.in
Verrica Pharmaceuticals Announces Financing of $50 Million - citybiz
Verrica Pharmaceuticals Secures $50M Financing Deal - TipRanks
Verrica Pharmaceuticals stock jumps after $50M financing deal By Investing.com - Investing.com Nigeria
Verrica Pharmaceuticals stock jumps after $50M financing deal - Investing.com India
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Deal - GuruFocus
Verrica Pharmaceuticals announces private placement financing of $50 million - TradingView
Verrica Pharmaceuticals (VRCA) Secures $50 Million Through PIPE Financing - GuruFocus
[8-K] Verrica Pharmaceuticals Inc. Reports Material Event | VRCA SEC FilingForm 8-K - Stock Titan
Verrica raises $50 million to repay debt, extend cash runway - Investing.com
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and ... - Enidnews.com
Verrica (NASDAQ: VRCA) Announces $50M PIPE to Retire OrbiMed Debt, Extend Runway to 2027 - Stock Titan
Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN
Verrica Pharmaceuticals Inc. announced that it expects to receive $50.067383 million in funding from BKB Growth Investments, LLC and other investors - MarketScreener
Why Verrica Pharmaceuticals Inc. (1NE) stock is a must watch tickerWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Verrica Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise - MSN
Verrica Posts Strong Q3 as YCANTH Momentum Builds and Late-Stage Pipeline Advances - MyChesCo
Can Verrica Pharmaceuticals Inc. (1NE) stock deliver consistent EPS growthInsider Buying & Long-Term Capital Growth Strategies - newser.com
How Verrica Pharmaceuticals Inc. (1NE) stock reacts to stronger dollarGold Moves & Short-Term Swing Trade Alerts - newser.com
How forex fluctuations impact Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com
What MACD trends signal for Verrica Pharmaceuticals Inc. (1NE) stockLayoff News & Reliable Breakout Forecasts - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock a top hedge fund pickJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
Can trapped investors hope for a rebound in Verrica Pharmaceuticals Inc.Portfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com
What RSI levels show for Verrica Pharmaceuticals Inc. (1NE) stockTake Profit & Consistent Growth Equity Picks - newser.com
Is Verrica Pharmaceuticals Inc. stock a smart buy before Fed meeting2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stock - newser.com
Why retail traders accumulate Verrica Pharmaceuticals Inc. (1NE) stockMarket Performance Summary & Verified Technical Signals - newser.com
Verrica Pharmaceuticals Inc. (VRCA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Published on: 2025-11-19 05:26:49 - newser.com
Should I buy Verrica Pharmaceuticals Inc. (1NE) stock before earnings seasonDollar Strength & Capital Efficiency Focused Ideas - newser.com
Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stockLong Setup & Weekly Top Gainers Alerts - newser.com
What Fibonacci levels say about Verrica Pharmaceuticals Inc. reboundWeekly Gains Report & Precise Swing Trade Alerts - newser.com
Verrica Pharmaceuticals Inc (VRCA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.16%
자본화:
|
볼륨(24시간):